CJC-1295 NO DAC and Hexarelin BLEND (2mg each = 4mg total)

Revo Peptide offers the CJC-1295 No DAC and Hexarelin Blend, a dual-peptide research formulation supplied at ≥98% purity and verified by independent analytical testing. Each vial contains 2mg of CJC-1295 No DAC and 2mg of Hexarelin, co-lyophilized into a single unit for streamlined laboratory handling. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

The CJC-1295 No DAC and Hexarelin Blend represents a strategically combined research peptide preparation designed to support investigations into growth hormone secretagogue pathways. CJC-1295 No DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH), while Hexarelin is a potent synthetic hexapeptide belonging to the growth hormone-releasing peptide (GHRP) family. When co-formulated, these two compounds offer researchers a convenient single-vial solution for studying synergistic secretagogue mechanisms in controlled laboratory environments. Available exclusively through Revo Peptide, this blend is produced under strict quality protocols to meet the demands of advanced peptide research.

Peptide Structure & Amino Acid Sequence

CJC-1295 No DAC is a 30-amino acid peptide with the following sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2. It is a modified GHRH analogue that lacks the Drug Affinity Complex (DAC) technology, resulting in a shorter active profile suitable for specific research protocols. Hexarelin, also known as Examorelin, is a synthetic hexapeptide with the sequence His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH2, classified as a GHS-R agonist. Its compact six-residue structure contributes to its notable receptor binding affinity in research models.

Chemical & Physical Characteristics

• CJC-1295 No DAC Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• CJC-1295 No DAC Molecular Weight: 3367.79 g/mol
• Hexarelin Molecular Formula: C₄₇H₅₈N₁₂O₆
• Hexarelin Molecular Weight: 887.06 g/mol
• Blend Content: 2mg CJC-1295 No DAC + 2mg Hexarelin per vial
• Physical Form: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffers under standard laboratory conditions
• Storage Temperature: −20°C (long-term); 2–8°C (short-term)

Purity & Analytical Verification (HPLC & MS)

Every batch of the CJC-1295 No DAC and Hexarelin Blend supplied by Revo Peptide undergoes rigorous analytical verification prior to release. Purity is confirmed at ≥98% using high-performance liquid chromatography (HPLC), and identity is validated through mass spectrometry (MS). Certificates of Analysis (CoA) are available upon request and reflect lot-specific data, ensuring that researchers can rely on consistent, reproducible results across experimental cycles. This level of analytical transparency is a cornerstone of Revo Peptide’s quality commitment.

Quality Control & Lyophilization Integrity

The blend is produced using pharmaceutical-grade lyophilization processes that preserve peptide structural integrity and extend shelf stability. Each vial is sealed under inert conditions to prevent moisture ingress and oxidative degradation. Lyophilized peptides from Revo Peptide are manufactured in compliance with established laboratory standards, and each production run is subject to multi-point quality control checkpoints covering appearance, moisture content, purity, and mass confirmation.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by qualified researchers in appropriately equipped laboratory settings. Standard laboratory safety protocols should be observed at all times when handling lyophilized peptide materials. Researchers should wear appropriate personal protective equipment (PPE), including gloves and eye protection, and should handle all materials in accordance with applicable institutional and regulatory guidelines. This compound is not approved for any use outside of in vitro or controlled preclinical research contexts.

Reconstitution, Packaging & Storage

The lyophilized blend should be reconstituted using a suitable aqueous solvent appropriate for the intended in vitro research application, under aseptic laboratory conditions. Each vial is individually packaged and labeled with lot number and content details to support accurate laboratory record-keeping. For long-term preservation of peptide integrity, store at −20°C in a dry, dark environment away from repeated freeze-thaw cycles. Short-term storage at 2–8°C is acceptable for active research periods not exceeding recommended durations per standard peptide handling guidelines.

Intended Research Use & Market Positioning

The CJC-1295 No DAC and Hexarelin Blend is intended for use in preclinical and in vitro research investigations exploring growth hormone secretagogue receptor interactions, pulsatile GH release mechanisms, and related endocrine signaling pathways. This dual-peptide blend is particularly relevant for researchers seeking to study the combinatorial effects of GHRH analogues and GHRP-class peptides within a single experimental framework. Revo Peptide positions this product as a premium research-grade blend for serious scientists requiring verified purity and reliable supply.

Ordering, Availability & Fulfillment

Buy the CJC-1295 No DAC and Hexarelin Blend online at Revo Peptide with confidence. We offer competitive best-price guarantees, secure checkout, and reliable domestic fulfillment. Bulk discount pricing is available for laboratory and institutional orders — save up to 20% when ordering 20 or more vials. All orders are processed promptly and shipped with appropriate cold-chain packaging to maintain peptide integrity during transit. Order now and experience the Revo Peptide standard of quality and service.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The CJC-1295 No DAC and Hexarelin Blend is sold strictly as a laboratory research reagent. Revo Peptide makes no claims regarding therapeutic efficacy, safety for human consumption, or suitability for any use outside of controlled scientific research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the procurement and use of research peptides. This product has not been evaluated or approved by any regulatory authority for medical or veterinary use.